“…Serotonin 2C (5-hydroxytryptamine, 5-HT 2C ) receptor activation, either by nonselective 5-HT 2C agonists such as m-chlorophenylpiperazine (m-CPP) and trifluoromethylphenylpiperazine (TFMPP) or the preferential 5-HT 2C agonist 6-chloro-2[1-piperazinyl]pyrazine (MK-212), has long been associated with anxiogenic-like profiles in a variety of animal models of anxiety, including the elevated plus-maze (EPM; Benjamin, Lal, & Meyerson, 1990;Kshama, Hrishikeshavan, Shanbhogue, & Munonyedi, 1990;Rodgers et al, 1992;Gibson et al, 1994;Griebel, Moreau, Jenck, Mutel, Martin, & Misslin, 1994;Fone, Shalders, Fox, Arthur, & Marsden, 1996;Wallis and Lal, 1998;Setem, Pinheiro, Motta, Morato, & Cruz, 1999;Jones, Duxon, & King, 2002;Bull, Huston, & Fone , 2003;Durand, Mormèd, & Chaouloff, 2003). In fact, newly selective 5-HT 2C agonists (e.g.…”